Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolo[3,4-d]pyrimidine compounds and their use as PDE2 inhibitors and/or CYP3A4 inhibitors

Pyrazolo[3,4-d]pyrimidine compounds and their use as PDE2 inhibitors and/or CYP3A4 inhibitors

US Patent 8829010 · Granted Sep 9, 2014

Estimated economic value: $296,433,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Piperazine azaspiro derivatives2025
Tricyclic compounds and their use as phosphodiesterase inhibitors2024
Tricyclic compounds and their use as phosphodiesterase inhibitors2024
Piperazine azaspiro derivatives2022
Tricyclic compounds and their use as phosphodiesterase inhibitors2022
Tricyclic compounds and their use as phosphodiesterase inhibitors2022
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands2022
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors2022
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors2022
Cyclic substituted imidazo[4,5-c]quinoline derivatives2021
Cyclic substituted imidazo[4,5-c]quinoline derivatives2021
Heterocyclic spiro compounds as MAGL inhibitors2020